Testing effectiveness (Phase 2)Not Yet RecruitingNCT07665996
What this trial is testing
A Phase Ib/IIa Study Assessing the Rapid Onset Characteristics of TLL-018 for Moderate-to-Severe CSU With Inadequate Response to Second-Generation H1 Antihistamines
Who this might be right for
Chronic Spontaneous Urticaria (CSU)
Hangzhou Highlightll Pharmaceutical Co., Ltd 36